Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

08/05/2026 07:34

May 8 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2026        Mar 31, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             3 mln                                         
  Operating     loss 420 mln        loss 785 mln                  
  Recurring     loss 413 mln        loss 810 mln                  
  Net           loss 414 mln        loss 811 mln                  
  EPS          loss 14.16 yen      loss 32.66 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T